查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1741086

按类型、疾病、技术和地区分類的基因检测市场

Genetic Testing Market, By Type, By Disease, and By Technology, and By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年基因检测市场规模估计为 230.4 亿美元，预计到 2032 年将达到 522.2 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 12.4%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 230.4亿美元
效能数据 从2020年到2024年 预测期 2025年至2032年
预测期：2025-2032年复合年增长率： 12.40% 2032年价值预测 522.2亿美元

基因检测是一种识别基因、染色体或蛋白质变化的医学检测。基因检测结果可以帮助确诊或排除疑似遗传疾病，或确定患有或遗传某种遗传疾病的可能性。基因检测在医学的许多领域都发挥着重要作用，可以改变人们接受的医疗保健方式。

市场动态：

遗传疾病和罕见疾病负担的增加、基因检测在肿瘤学中的应用的增加、基因检测用途的扩大、个性化医疗的需求增加以及直接面向消费者的基因检测需求的增加是预计在预测期内促进全球基因检测市场增长的关键因素。

例如，2022 年 6 月，基因组和诊断测试领域的领导者之一 Prenetics Group Limited 推出了 ColoClear by Circle（ColoClear），这是一种新型的非侵入性家庭筛检测试，用于检测结直肠癌的早期迹象。

2022 年 3 月，基因组序列测定集团 Illumina 将在欧洲推出一项癌症检测，该检测可以检查单一组织样本中的多种肿瘤基因，可能有助于为患有罕见疾病的患者提供匹配的治疗方法。

本研究的主要特点

  • 本报告对全球基因检测市场进行了详细分析，并提供了预测期 2025-2032（以 2024 年为基准年）的市场规模和年复合成长率(CAGR)。
  • 它还揭示了各个领域的潜在商机，并说明了该市场的引人注目的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 该报告涵盖了全球基因检测市场的主要企业概况，基于以下参数，例如公司亮点、产品系列、主要亮点、财务表现和策略。
  • 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球基因检测市场报告迎合了该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员将透过用于分析全球基因检测市场的各种策略矩阵来做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

  • 市场动态
    • 遗传疾病和罕见疾病的负担日益加重
    • 基因检测费用高昂
    • 扩大基因检测的应用
  • 影响分析
  • 主要亮点
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景

第四章全球基因检测市场-冠状病毒（COVID-19）大流行的影响

  • COVID-19流行病学
  • 供需侧分析
  • 经济影响

5. 全球基因检测市场（按类型），2020 年至 2032 年

  • 职业测试
  • 诊断测试
  • 新生儿筛检
  • 预测性和症状前检测
  • 产前检查
  • 其他类型

6. 2020 年至 2032 年全球基因检测市场（依疾病分类）

  • 阿兹海默症
  • 癌症
  • 囊肿纤维化
  • 镰状细胞性贫血
  • Duchenne氏肌肉失养症
  • 地中海型贫血
  • 亨丁顿舞蹈症
  • 罕见疾病
  • 其他疾病

7. 全球基因检测市场（依技术划分），2020 年至 2032 年

  • 细胞遗传学检测
  • 生物化学检验
  • 分子检测

8. 全球基因检测市场（按地区划分），2020-2032 年

  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

第九章 竞争态势

  • 23&Me Inc.
  • Qiagen NV
  • Eurofins Scientific
  • PerkinElmer Inc.
  • Illumina Inc.
  • Danaher Corporation
  • Myriad Genetics Inc.
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Quest Diagnostics Incorporated
  • BioRad Laboratories Inc.
  • DiaSorin SpA（Luminex Corporation）

第 10 章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI5802

Genetic Testing Market is estimated to be valued at USD 23.04 Bn in 2025 and is expected to reach USD 52.22 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.4% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 23.04 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 12.40% 2032 Value Projection: USD 52.22 Bn

Genetic testing is a type of medical test that identifies changes in genes, chromosomes, or proteins. The results of a genetic test can confirm or rule out a suspected genetic condition or help determine a person's chance of developing or passing on a genetic disorder. Genetic testing is useful in many areas of medicine and can change the medical care people receives.

Market Dynamics:

Rise in burden of genetic and rare disorders, increasing application of genetic testing in oncology, growing applications of genetic testing, high demand for personalized medicine, and increasing demand for direct-to-consumer genetic testing are major factors expected to augment the growth of the global genetic testing market over the forecast period.

For instance, in June 2022, Prenetics Group Limited, one of the leaders in genomic and diagnostic testing, introduced a novel, non-invasive at-home screening test, ColoClear by Circle (ColoClear), for detecting early signs of colorectal cancer.

Moreover, in March 2022, Illumina, a genome sequencing group, launched a cancer test in Europe that checks for a wide range of tumor genes in one tissue sample, potentially helping patients with rare diseases to be matched up with treatment options.

Key features of the study:

  • This report provides in-depth analysis of the global genetic testing market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global genetic testing market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include 23&Me Inc., Qiagen NV, Eurofins Scientific, PerkinElmer Inc., Illumina Inc., Danaher Corporation, Myriad Genetics Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Quest Diagnostics Incorporated, BioRad Laboratories Inc., and DiaSorin S.p.A. (Luminex Corporation), among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global genetic testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global genetic testing market.

Detailed Segmentation:

  • Global Genetic Testing Market, By Type:
    • Carrier Testing
    • Diagnostic Testing
    • New-born Screening
    • Predictive and Presymptomatic Testing
    • Prenatal Testing
    • Other Types
  • Global Genetic Testing Market, By Disease:
    • Alzheimer's Disease
    • Cancer
    • Cystic Fibrosis
    • Sickle Cell Anemia
    • Duchenne Muscular Dystrophy
    • Thalassemia
    • Huntington's Disease
    • Rare Diseases
    • Other Diseases
  • Global Genetic Testing Market, By Technology:
    • Cytogenetic Testing
    • Biochemical Testing
    • Molecular Testing
  • Global Genetic Testing Market, By Geography:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • 23&Me Inc.
    • Qiagen NV
    • Eurofins Scientific
    • PerkinElmer Inc.
    • Illumina Inc.
    • Danaher Corporation
    • Myriad Genetics Inc.
    • Abbott Laboratories
    • Hoffmann-La Roche Ltd.
    • Quest Diagnostics Incorporated
    • BioRad Laboratories Inc.
    • DiaSorin S.p.A. (Luminex Corporation)

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Disease
    • Market Snapshot, By Technology
    • Market Genetic Testing, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rise in burden of genetic/rare disorders
    • High cost of genetic testing
    • Growing applications of genetic testing
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Genetic Testing Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Genetic Testing Market, By Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Carrier Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Diagnostic Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • New-born Screening
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Predictive and Presymptomatic Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Prenatal Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Other Types
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Genetic Testing Market, By Disease, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Alzheimer's Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Cystic Fibrosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Sickle Cell Anemia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Duchenne Muscular Dystrophy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Thalassemia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Huntington's Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Rare Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Other Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Genetic Testing Market, By Technology, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Cytogenetic Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Biochemical Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Molecular Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Genetic Testing Market, By Geography, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)

9. Competitive Landscape

  • 23&Me Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Qiagen NV
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Eurofins Scientific
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • PerkinElmer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Illumina Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Danaher Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Myriad Genetics Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • F. Hoffmann-La Roche Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Quest Diagnostics Incorporated
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BioRad Laboratories Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • DiaSorin S.p.A. (Luminex Corporation)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us